Biotronik SE & Co KG - Company Profile
Powered by 
All the sales intelligence you need on Biotronik SE & Co KG in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Biotronik SE & Co KG fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Biotronik SE & Co KG.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Biotronik SE & Co KG (Biotronik) is a medical device company that develops, manufactures, and distributes cardiovascular and endovascular solutions. The company’s cardiac rhythm management solutions include implantable devices, leads, and accessories and external devices to treat and manage arrhythmia-related diseases. Its electrophysiology products include heart catheters used to diagnose and treat cardiac arrhythmias; and vascular intervention products such as stent systems, balloon catheters, and guide wires for the treatment of peripheral, and coronary artery diseases. The company has manufacturing facilities in Germany, Singapore, Switzerland, and the US. Biotronik is headquartered in Berlin, Germany.
Headquarters
Germany
Address
Woermannkehre 1, Berlin, 12359
Website
www.biotronik.com
Telephone
49 30 689050
Industry
Medical Equipment
Biotronik SE & Co KG premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Cardiac Rhythm Management: | BioVantage |
| Pacemakers | Freesolve |
| Implantable Defibrillators | Micro Rx |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | New Products/Services | In February, the company announced the launch of the new Acticor Sky and Rivacor Sky device. |
| 2025 | Contracts/Agreements | In October, the company entered into a partnership with University of Sydney to transform cardiac care through digital innovation. |
| 2025 | New Products/Services | In September, the company announced the launch of Solia CSP S, the latest innovation in its growing portfolio of Conduction System Pacing (CSP) solutions. |
Competitor Comparison
| Key Parameters | Biotronik SE & Co KG | Abbott Laboratories | Medtronic Plc | Acandis GmbH & Co KG | Eurocor Tech GmbH |
|---|---|---|---|---|---|
| Headquarters | Germany | United States of America | Ireland | Germany | Germany |
| City | Berlin | Abbott Park | Dublin | Pforzheim | Bonn |
| State/Province | Berlin | Illinois | - | Baden-Wurttemberg | - |
| No. of Employees | - | 115,000 | 95,000 | 285 | 15 |
| Entity Type | Private | Public | Public | Private | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Alexander Uhl | Chief Executive Officer | Senior Management | 2022 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer